This study provides the first evidence of tet(X4)-carrying E. coli in IBS-D patients and highlights the diversity and mobility of associated plasmids. These findings underscore the need for continued surveillance of plasmid-mediated tigecycline resistance in clinical gastrointestinal populations.
Wu et al. (Wed,) studied this question.